FDA Rejects Ban on Darvon, Darvocet

Although an FDA panel recommended a ban of the painkiller propoxyphene because of the risk of overdose, the FDA has chosen not to ban the drug (found in Darvon, Darvocet etc) but rather to make a few changes to the requirements of manufactures as to what's put on their labels. A public interest group had petitioned the FDA to enter into a phased withdrawal of propoxyphene. Their petition was denied.

Ultimately, the FDA decided that the benefits of propoxyphene, which first hit the US market in 1957, outweigh the risks.

Actions taken by the FDA regarding propoxyphene

--They will require manufacturers of propoxyphene-containing products to strengthen the label, including the boxed warning, emphasizing the potential for overdose when using these products. (Manufacturers have 30 days to submit to the FDA these changes, or to provide a reason why they do not believe such changes are necessary.)

--They will require manufacturers to provide a medication guide to patients stressing the importance of using the drugs as directed.

-- They will require a new safety study assessing unanswered questions about the effects of propoxyphene on the heart at higher than recommended doses. Findings from this study, as well as other data, could lead to additional regulatory action.

From the FDA's Center for Drug Evaluation and Research

A word to doctors and patients from Dr Janet Woodcock, director, of the FDA Center for Drug Evaluation and Research:

“Physicians need to be aware of the risk of overdose when prescribing these drugs. They should carefully review patient histories and make appropriate treatment decisions based on the warnings and directions stated within the drug’s label."

“Prescribers and patients should be aware of propoxyphene’s potential risks when used at doses higher than those recommended. Therefore, the FDA is requiring manufacturers to provide more information to help physicians and patients decide whether propoxyphene is the appropriate pain therapy.”

External links

You can read the FDA's press release HERE.

You can read a Q&A on propoxyphene by the FDA HERE

I am taking darvocet since

I am taking darvocet since long time and I never had any side effects also never face any problem due to this medicines. I strongly oppose to ban on this medicines. Darvocet really help me a lot. I usually order Darvocet from online pharmacy darvocetinformation.com.

Follow LymphomaInfo.net on:

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.


 
disclaimer

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

Poll

Why Did You Visit This Site?:

Related Ads

You May Also Want To Read

 

Other People Are Reading

 

LymphomaInfo Social

SupportGroups.com

visit SupportGroups.com

SupportGroups.com provides a support network for those dealing with cancer and other life's challenges. Click on the following links to get the support in a confidential, caring environment.

Cancer Support Groups

 

lymphomas